Quality of end-of-life care in patients with hematologic malignancies: A retrospective cohort study

Cancer

Volumn 120, Issue 10, 2014, Pages 1572-1578

  Hui, David ^a   Didwaniya, Neha ^a   Vidal, Marieberta ^a   Shin, Seong Hoon ^b   Chisholm, Gary ^a   Roquemore, Joyce ^a   Bruera, Eduardo ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b Kosin University   (South Korea)

Author keywords

chemotherapeutic agents; emergency medicine; end of life; hematologic neoplasms; intensive care; palliative care; quality of care; targeted agents

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; COHORT ANALYSIS; CONTROLLED STUDY; DRUG USE; EMERGENCY WARD; FEMALE; HEALTH CARE QUALITY; HEMATOLOGIC MALIGNANCY; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MOLECULARLY TARGETED THERAPY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SOLID TUMOR; SYSTEMIC THERAPY; TERMINAL CARE; VERY ELDERLY;

CHEMOTHERAPEUTIC AGENTS; EMERGENCY MEDICINE; END OF LIFE; HEMATOLOGIC NEOPLASMS; INTENSIVE CARE; PALLIATIVE CARE; QUALITY OF CARE; TARGETED AGENTS;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEMATOLOGIC NEOPLASMS; HOSPICE CARE; HUMANS; INTENSIVE CARE; LENGTH OF STAY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; ODDS RATIO; PALLIATIVE CARE; QUALITY OF HEALTH CARE; QUALITY OF LIFE; RETROSPECTIVE STUDIES; TERMINAL CARE; TEXAS;

EID: 84899952449     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28614     Document Type: Article

References (32)

1. Fadul NA, El Osta B, Dalal S, Poulter VA, Bruera E,. Comparison of symptom burden among patients referred to palliative care with hematologic malignancies versus those with solid tumors. J Palliat Med. 2008; 11: 422-427.
2. Manitta V, Zordan R, Cole-Sinclair M, Nandurkar H, Philip J,. The symptom burden of patients with hematological malignancy: a cross-sectional observational study. J Pain Symptom Manage. 2011; 42: 432-442.
3. McGrath P, Holewa H,. Special considerations for haematology patients in relation to end-of-life care: Australian findings. Eur J Cancer Care (Engl). 2007; 16: 164-171.
4. Bousquet A, Malfuson JV, Sanmartin N, et al. An 8-year survey of strains identified in blood cultures in a clinical haematology unit. Clin Microbiol Infect. 2014; 20: O7-O12.
5. Franchini M, Frattini F, Crestani S, Bonfanti C,. Bleeding complications in patients with hematologic malignancies. Semin Thromb Hemost. 2013; 39: 94-100.
6. Hui D, Karuturi MS, Tanco KC, et al. Targeted agent use in cancer patients at the end of life. J Pain Symptom Manage. 2013; 46: 1-8.
7. Hui D, Elsayem A, Li Z, De La Cruz M, Palmer JL, Bruera E,. Antineoplastic therapy use in patients with advanced cancer admitted to an acute palliative care unit at a comprehensive cancer center: a simultaneous care model. Cancer. 2010; 116: 2036-2043.
8. Bishop MM, Beaumont JL, Hahn EA, et al. Late effects of cancer and hematopoietic stem-cell transplantation on spouses or partners compared with survivors and survivor-matched controls. J Clin Oncol. 2007; 25: 1403-1411.
9. Rodin G, Yuen D, Mischitelle A, et al. Traumatic stress in acute leukemia. Psychooncology. 2013; 22: 299-307.
10. Tang ST, Wu SC, Hung YN, Chen JS, Huang EW, Liu TW,. Determinants of aggressive end-of-life care for Taiwanese cancer decedents, 2001 to 2006. J Clin Oncol. 2009; 27: 4613-4618.
11. Ho TH, Barbera L, Saskin R, Lu H, Neville BA, Earle CC,. Trends in the aggressiveness of end-of-life cancer care in the universal health care system of Ontario, Canada. J Clin Oncol. 2011; 29: 1587-1591.
12. Hui D, Kim SH, Kwon JH, et al. Access to palliative care among patients treated at a comprehensive cancer center. Oncologist. 2012; 17: 1574-1580.
13. Keating NL, Landrum MB, Lamont EB, Earle CC, Bozeman SR, McNeil BJ,. End-of-life care for older cancer patients in the Veterans Health Administration versus the private sector. Cancer. 2010; 116: 3732-3739.
14. Earle CC, Neville BA, Landrum MB, Ayanian JZ, Block SD, Weeks JC,. Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol. 2004; 22: 315-321.
15. Earle CC, Park ER, Lai B, Weeks JC, Ayanian JZ, Block S,. Identifying potential indicators of the quality of end-of-life cancer care from administrative data. J Clin Oncol. 2003; 21: 1133-1138.
16. National Quality Forum. Cancer Endorsement Maintenance. qualityforum.org/Publications/2012/12/Cancer-Endorsement-Maintenance-2011.aspx. Accessed May 7, 2013.
17. American Society of Clinical Oncology. Quality Oncology Practice Initiative. The Quality Oncology Practice Initiative Quality Measures. qopi.asco.org/program.html. Accessed May 13, 2013.
18. National Cancer Institute, National Institutes of Health. Dictionary of Cancer Terms: Targeted Therapy. cancer.gov/dictionary?cdrid=270742. Accessed March 5, 2012.
19. Howell DA, Roman E, Cox H, et al. Destined to die in hospital? Systematic review and meta-analysis of place of death in haematological malignancy. BMC Palliat Care. 2010; 9: 9.
20. Hampshire PA, Welch CA, McCrossan LA, Francis K, Harrison DA,. Admission factors associated with hospital mortality in patients with haematological malignancy admitted to UK adult, general critical care units: a secondary analysis of the ICNARC Case Mix Programme Database. Crit Care. 2009; 13: R137.
21. Wright AA, Keating NL, Balboni TA, Matulonis UA, Block SD, Prigerson HG,. Place of death: correlations with quality of life of patients with cancer and predictors of bereaved caregivers' mental health. J Clin Oncol. 2010; 28: 4457-4464.
22. Wright AA, Zhang B, Ray A, et al. Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA. 2008; 300: 1665-1673.
23. Hui D, Elsayem A, Palla S, et al. Discharge outcomes and survival of patients with advanced cancer admitted to an acute palliative care unit at a comprehensive cancer center. J Palliat Med. 2010; 13: 49-57.
24. Lagman R, Rivera N, Walsh D, LeGrand S, Davis MP,. Acute inpatient palliative medicine in a cancer center: clinical problems and medical interventions-a prospective study. Am J Hosp Palliat Care. 2007; 24: 20-28.
25. Osta BE, Palmer JL, Paraskevopoulos T, et al. Interval between first palliative care consult and death in patients diagnosed with advanced cancer at a comprehensive cancer center. J Palliat Med. 2008; 11: 51-57.
26. Fadul N, Elsayem A, Palmer JL, Zhang T, Braiteh F, Bruera E,. Predictors of access to palliative care services among patients who died at a Comprehensive Cancer Center. J Palliat Med. 2007; 10: 1146-1152.
27. Cheng WW, Willey J, Palmer JL, Zhang T, Bruera E,. Interval between palliative care referral and death among patients treated at a comprehensive cancer center. J Palliat Med. 2005; 8: 1025-1032.
28. Kao CY, Wang HM, Tang SC, et al. Predictive factors for do-not-resuscitate designation among terminally ill cancer patients receiving care from a palliative care consultation service [published online ahead of print July 12, 2013]. J Pain Symptom Manage. pii: S0885-392400311-4. doi: 10.1016/j.jpainsymman. 2013.03.020.
29. Temel JS, Greer JA, Admane S, et al. Longitudinal perceptions of prognosis and goals of therapy in patients with metastatic non-small-cell lung cancer: results of a randomized study of early palliative care. J Clin Oncol. 2011; 29: 2319-2326.
30. Barbera L, Taylor C, Dudgeon D,. Why do patients with cancer visit the emergency department near the end of life? CMAJ. 2010; 182: 563-568.
31. National Comprehensive Cancer Network. NCCN Guidelines for Treatment of Cancer. nccn.org/professionals/physician-gls/f-guidelines.asp. Accessed October 8, 2013.
32. National Hospice and Palliative Care Organization. NHPCO's Facts & Figures on Hospice. nhpco.org/hospice-statistics-research-press-room/facts- hospice-and-palliative-care. Accessed August 27, 2013.